Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
Publication
Artículo científico (JournalArticle)
Radiotherapy synergizes with an inducible AAV-based immunotherapy platform to program local and systemic antitumor immunity
Radiotherapy (RT) can prime the immune system against cancer but often fails to generate effective antitumor responses due to concomitant induction of immunosuppressive factors. To overcome this limitation,
we built upon the observation that RT enhances adeno-associated vectors (AAVs) tumor transduction
through the epigenetic modification of vector episomes. We designed an AAV-based platform to deliver immunostimulatory cytokines through an interferon (IFN)-inducible promoter that allows for spatial control of
transgene expression into irradiated tumors. As opposed to a constitutive system, local delivery of a vector
encoding for inducible IL-12 (AAV-iIL12) achieves an efficient production of the cytokine without significant
toxicity. Combination of RT and AAV-iIL12 generates a highly immunostimulatory tumor microenvironment
(TME) leading to robust local and systemic antitumor responses in an IFNγ- and FAS-dependent manner,
able to overcome common immune-evasion mechanisms. Our work shows that radiation coupled with
AAV-based immune-gene delivery is an efficient and safe approach to treat cancer., This work was supported by grants PID2024-160227OB-I00 (funded by MICIU/AEI/10.13039/501100011033 and FEDER, EU), NAIARA Project (ref. 0011-1411-2025-000144, funded by Gobierno de Navarra and FEDER 2021-2027), PID2020-113963RBI00 from AEI, Aragon Government (B29-20R) and CIBERINFEC/Instituto de Salud Carlos III, (CB21/13/00087).
Project:
AEI / Plan Estatal de Investigación Científica PID2024-160227OB-I00
,
AEI / Técnica y de Innovación 2024-2027 PID2020-113963RB-I00
,
ISCIII / Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020 CB21-13-00087
,
Gobierno de Navarra 0011-1411-2025-000144
View at: https://hdl.handle.net/2454/56924